AMBRA1 is a predictive biomarker of melanoma response to targeted therapy
Saved in:
| Main Authors: | L. Di Leo, C. Pagliuca, A. Kishk, S. Rizza, C. Tsiavou, C. Pecorari, C. Dahl, M. Pacheco, R. Tholstrup, J. Brewer, P. Berico, E. Hernando, F. Cecconi, R. Ballotti, C. Bertolotto, G. Filomeni, M. Gjerstorff, T. Sauter, P. Lovat, P. Guldberg, D. De Zio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S277261182400106X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prolonged Pseudohypoxia Targets Ambra1 mRNA to P-Bodies for Translational Repression.
by: Somayeh Pourpirali, et al.
Published: (2015-01-01) -
Zebrafish ambra1a and ambra1b knockdown impairs skeletal muscle development.
by: Tatjana Skobo, et al.
Published: (2014-01-01) -
Loss of AMBRA1 expression in the tumour endothelium as a potential biomarker to identify AJCC stage I/II melanomas at high risk of metastasis
by: P. Lovat, et al.
Published: (2024-01-01) -
Ambra1 is an essential regulator of autophagy and apoptosis in SW620 cells: pro-survival role of Ambra1.
by: Wen Gu, et al.
Published: (2014-01-01) -
Exploring Melanoma Dynamics: Insights from a 3D Cell Culture Model with Vemurafenib Treatment
by: Tholstrup Rikke, et al.
Published: (2024-01-01)